ArticleBMJ global health2020

Cost-effectiveness of new antiviral treatments for non-genotype 1 hepatitis C virus infection in China: a societal perspective.

Xia Wei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.